

We are a clinical stage biopharmaceutical company advancing a robust pipeline of drug candidates to address a spectrum of large, unmet medical needs. We are focused on harnessing powerful, untapped biology underlying major diseases to develop transformative therapeutics for patients. Among its major competitors, NGM Biopharmaceuticals is ranked in 9th place for NPS while Nektar Therapeutics is 1st, and Revance Therapeutics is 2nd. Overall, NGM Biopharmaceuticals has a neutral social sentiment, when analyzing social media channels and online mentions.Their current market cap is $280.84M
NGM Biopharmaceuticals's Net Promoter Score (NPS) is a 20 with 60% Promoters, 0% Passives, and 40% Detractors. Net Promoter Score tracks whether NGM Biopharmaceuticals's customers would recommend using the product based on a scale of -100 to 100.
| 60% | Promoters |
|---|---|
| 0% | Passives |
| 40% | Detractors |
| Summary | Date | Score |
|---|---|---|
May 2021 100 | May 2021 | 100 |
May 2022 100 | May 2022 | 100 |
Nov 2022 100 | Nov 2022 | 100 |
May 2023 20 | May 2023 | 20 |
NGM Biopharmaceuticals is ranked #4 for NPS among its competitors. Merck and Genentech come in first and second, with AbbVie coming in at third. Among those competitors, it is the lowest valued company behind Merck.
Net Promoter Score (NPS) is a management tool that can be used to gauge the satisfaction of a firm's customer relationships. NPS has been widely adopted as a key metric often linked to the revenue potential of a company’s product or service. The metric is based on customer responses to the question: "On a scale of 0 to 10, how likely are you to recommend the product to a friend?"
Those who respond with a score of 9 to 10 are known as Promoters, and are widely associated with behaviors that create value, including actively encouraging others to use the product or service. Those who respond with a score of 7 or 8 are categorized as Passives, and they are believed to be less likely to exhibit the value-creation traits of Promoters having a largely neutral effect on other consumers. Detractors are those who fall in the score range of 0 to 6 and represent dissatisfied customers of the product sometimes actively recommending against using the product.
Compared to its competitors, NGM Biopharmaceuticals's NPS is rated right above Verily, and is preceded by Gilead Sciences.
Customer Loyalty is a strong indicator of whether or not a customer will choose a brand repeatedly over a competitor that offers similar products/services.
100% of NGM Biopharmaceuticals users/customers answered "Yes" when asked: "Would you consider yourself a loyal user/customer?"
Sign Up to see the full customer demographics data and the people that answered "Yes" when asked "Would you consider yourself a loyal user/customer?"
Compared to its competitors, NGM Biopharmaceuticals's Customer Loyalty score is rated right above MyoKardia.
| COMPANY | Customer Loyalty Score | |
|---|---|---|
![]() | NGM Biopharmaceuticals | 100% |
![]() | MyoKardia | 100% |
![]() | Revance Therapeutics | 84% |
![]() | Merck | 80% |
![]() | Genentech | 79% |
![]() | Amgen | 77% |
![]() | AbbVie | 73% |
![]() | Gilead Sciences | 71% |
![]() | BioMarin Pharmaceutical Inc. | 69% |
![]() | Verily | 57% |
![]() | Nektar Therapeutics | N/A |
![]() | Pharmacyclics | N/A |
![]() | Crescendo Bioscience | N/A |
![]() | Portola Pharmaceuticals | N/A |
![]() | Principia BioPharma | N/A |
NGM Biopharmaceuticals has an overall Product Quality score of 3.2 out of 5 stars rated by its users and customers.
Sign Up to unlock NGM Biopharmaceuticals' overall Product Quality score rated by its users and customers.
NGM Biopharmaceuticals’s product quality score is a 3.2 out of 5 as rated by its users and customers.
Compared to its competitors, NGM Biopharmaceuticals's Product Quality score is rated right above Pharmacyclics, and is preceded by Verily.
| COMPANY | Product Quality Score | |
|---|---|---|
![]() | Revance Therapeutics | 4.2/5 |
![]() | BioMarin Pharmaceutical Inc. | 4/5 |
![]() | Merck | 4/5 |
![]() | Genentech | 4/5 |
![]() | MyoKardia | 4/5 |
![]() | Amgen | 3.8/5 |
![]() | Gilead Sciences | 3.8/5 |
![]() | AbbVie | 3.7/5 |
![]() | Verily | 3.3/5 |
![]() | NGM Biopharmaceuticals | 3.2/5 |
![]() | Pharmacyclics | 1.5/5 |
![]() | Nektar Therapeutics | N/A |
![]() | Crescendo Bioscience | N/A |
![]() | Portola Pharmaceuticals | N/A |
![]() | Principia BioPharma | N/A |
NGM Biopharmaceuticals has a value for money and ROI score of 4.1 out of 5 stars rated by its users and customers.
Sign Up to unlock NGM Biopharmaceuticals' overall ROI score rated by its users and customers.
Compared to its competitors, NGM Biopharmaceuticals's ROI score is rated right above Merck, and is preceded by Revance Therapeutics.
| COMPANY | Pricing Score | |
|---|---|---|
![]() | Revance Therapeutics | 4.2/5 |
![]() | NGM Biopharmaceuticals | 4.1/5 |
![]() | Merck | 4/5 |
![]() | MyoKardia | 4/5 |
![]() | Genentech | 3.8/5 |
![]() | BioMarin Pharmaceutical Inc. | 3.8/5 |
![]() | Amgen | 3.8/5 |
![]() | AbbVie | 3.8/5 |
![]() | Gilead Sciences | 3.6/5 |
![]() | Verily | 3.6/5 |
![]() | Nektar Therapeutics | N/A |
![]() | Pharmacyclics | N/A |
![]() | Crescendo Bioscience | N/A |
![]() | Portola Pharmaceuticals | N/A |
![]() | Principia BioPharma | N/A |
NGM Biopharmaceuticals has an overall Customer Satisfaction score of 50 rated by its users and customers.
Sign Up to see the full customer demographics data and the people that answered "How would you rate your overall satisfaction with the service you received?"
Customer Satisfaction Score (also known as CSAT), is a metric used to quantify how satisfied customers are with a company or brand’s products and services. The Customer Satisfaction Score is based on customers response to the question: “How would you rate your overall satisfaction with the service you received?” The score is calculated using the formula: (The total number answer of “Very Satisfied” and “Satisfied”) ÷ (The total response) x100, and it is generally displayed in percentages. Some of the main benefits of the CSAT for businesses are tracking retention, identifying happy customers and growing relationships, and gaining repeat business to build a sustainable brand.
Compared to its competitors, NGM Biopharmaceuticals's Customer Satisfaction score is rated right above Nektar Therapeutics, and is preceded by Verily.
| COMPANY | Customer Satisfaction (CSAT) Score | |
|---|---|---|
![]() | BioMarin Pharmaceutical Inc. | 83% |
![]() | Merck | 79% |
![]() | Genentech | 78% |
![]() | Amgen | 67% |
![]() | AbbVie | 65% |
![]() | Revance Therapeutics | 64% |
![]() | Gilead Sciences | 64% |
![]() | Verily | 64% |
![]() | NGM Biopharmaceuticals | 50% |
![]() | Nektar Therapeutics | 0% |
![]() | Pharmacyclics | 0% |
![]() | Crescendo Bioscience | 0% |
![]() | MyoKardia | 0% |
![]() | Portola Pharmaceuticals | 0% |
![]() | Principia BioPharma | 0% |
NGM Biopharmaceuticals has an overall Customer Service score of 5 out of 5 stars rated by its users and customers.
Sign Up to unlock NGM Biopharmaceuticals' overall Customer Service score rated by its users and customers.
333 Oyster Point Boulevard, South San Francisco, CA 94080
http://www.ngmbio.com
6505831646
Compared to its competitors, NGM Biopharmaceuticals's Customer Service score is rated right above Merck.
| COMPANY | Customer Service Score | |
|---|---|---|
![]() | NGM Biopharmaceuticals | 5/5 |
![]() | Merck | 4.2/5 |
![]() | Revance Therapeutics | 4.1/5 |
![]() | MyoKardia | 4/5 |
![]() | Genentech | 3.9/5 |
![]() | Amgen | 3.9/5 |
![]() | Gilead Sciences | 3.9/5 |
![]() | BioMarin Pharmaceutical Inc. | 3.8/5 |
![]() | AbbVie | 3.8/5 |
![]() | Verily | 3.8/5 |
![]() | Nektar Therapeutics | N/A |
![]() | Pharmacyclics | N/A |
![]() | Crescendo Bioscience | N/A |
![]() | Portola Pharmaceuticals | N/A |
![]() | Principia BioPharma | N/A |
NGM Biopharmaceuticals has a 4.3/5 stars for its overall company culture rated by their employees

NGM Biopharmaceuticals scored a 20 for Net Promoter Score and a 61 for Employee Net Promoter Score. NPS gauges how likely a customer of NGM Biopharmaceuticals would recommend the brand to a friend. ENPS measures how likely NGM Biopharmaceuticals employees would recommend working at NGM Biopharmaceuticals to a friend.
| 60% | Promoters |
|---|---|
| 0% | Passive |
| 40% | Detractors |
| 74% | Promoters |
|---|---|
| 13% | Passive |
| 13% | Detractors |